Scilex signs distribution agreement for ZTlido for parts of Africa, Middle East

Scilex announced a Master Distributor Agreement with Devart Middle East Food, as Master Distributor, and CH Trading Group, as Territories Distributor, to expand the distribution of ZTlido into the countries of Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa. The Master Distributor Agreement is an outgrowth Scilex’s existing Product Distribution Agreement with CH Trading Group, under which CH Trading Group is continuing the process of expanding commercialization of ZTlido in the Middle East and North/South Africa markets and has the opportunity to distribute across the broader Islamic world and further expand the relationship for other products in Scilex’s non-opioid pain portfolio. Under the Master Distributor Agreement, Devart Middle East assumes the responsibility, among other things, of promoting, marketing, selling and distributing ZTlido, and potentially other Scilex products, through a network of business associates, into the above Designated Territories. ZTlido is a lidocaine topical system approved for the relief of neuropathic pain associated with post-herpetic neuralgia.